Multicomponent reactions are prized in organic synthesis because they stitch together three or more simple molecules in a single operation, rapidly building molecular complexity and diversity while minimizing purification steps. Yet this efficiency comes with a catch. When several nucleophiles—electron-rich species that donate electron pairs to form new bonds—are present in the same flask, they tend to compete for the same electrophilic partner, producing chaotic mixtures of products. Chemists have long coped with this by pre-functionalizing substrates, installing protecting groups or activating handles that exaggerate the reactivity differences between partners. Such workarounds add steps, generate waste and undermine the atom economy that makes multicomponent chemistry attractive in the first place.

The new study takes a different tack. Rather than modifying the nucleophiles themselves, the researchers exploited the dual personality of a palladium–propargyl complex, a reactive intermediate generated when a palladium catalyst engages a propargylic carbonate—a common and easily prepared class of propargyl electrophiles. When palladium inserts into the carbon–oxygen bond of the carbonate with loss of carbon dioxide, it forms what chemists call an η3-propargyl–palladium species. Crucially, this intermediate can be represented as two resonance forms: a propargyl form and an allenyl form. The team recognized that this tandem reactivity could serve as a built-in sorting mechanism, offering two distinct electrophilic targets within the same metal complex.

The sorting logic works as follows. Stronger nucleophiles in the reaction mixture undergo outer-sphere addition to the propargyl–palladium intermediate, attacking the organic ligand directly from outside the coordination sphere of the metal. Weaker nucleophiles, by contrast, cannot compete on reactivity alone. Instead, they are guided by their superior coordinating affinity—their tendency to bind directly to the palladium center. Once coordinated, these weaker partners attack the resulting allyl–palladium species through an inner-sphere mechanism, in which the bond-forming event occurs from within the metal complex. The two pathways are orthogonal: each class of nucleophile is routed to a different intermediate and a different position in the product, purely on the basis of its intrinsic physical properties.

This elegant division of labor allows the precise recognition and ordered incorporation of diverse pairs of native N–H and O–H nucleophiles—amines and alcohols bearing no protecting groups or artificial activation. The upshot is a modular platform for constructing chiral 1,2-amino alcohols and 1,2-diols with what the authors describe as exceptional regio-, chemo-, Z- and enantiocontrol. In practical terms, the reaction decides correctly which nitrogen or oxygen attaches where along the carbon chain, whether the alkene geometry is the Z isomer, and which enantiomer of the product predominates—all in a single catalytic operation starting from fundamental feedstock chemicals.

The significance of that selectivity profile is hard to overstate. Vicinal amino alcohols—molecules bearing an amine and an alcohol on adjacent carbons—are among the most consequential chiral building blocks in chemistry. The cis-1-amino-2-indanol core, for example, features prominently in drug design and asymmetric processes, as documented in a classic Chemical Reviews survey. Amino alcohol motifs appear in HIV protease inhibitors, in the plant growth regulator uniconazole, in antitussive Stemona alkaloids such as stemoninine, and in daryamide natural products isolated from marine Streptomyces bacteria. Beyond their presence in bioactive molecules, amino alcohols and their heterocyclic derivatives serve as chiral auxiliaries and as nitrogen-containing ligands for asymmetric catalysis, including the widely used pyridine–oxazoline family.

Existing routes to enantioenriched amino alcohols each carry limitations. Asymmetric hydrogenation of prochiral amino ketones, pioneered for pharmaceutical manufacturing, requires specialized equipment and carefully matched catalysts. The Sharpless asymmetric aminohydroxylation of olefins, introduced in 1996, delivers vicinal amino alcohols directly but is constrained in scope by its osmium-based chemistry. Subsequent decades brought copper-catalyzed radical oxyfunctionalization of alkenes, palladium-catalyzed aminoacetoxylation, iridium nitrenoid chemistry, organoiodine-catalyzed oxyamination and rhodium-catalyzed diene functionalization—each expanding the toolbox, yet typically demanding pre-oxidized or specially activated substrates, or delivering only one of the two heteroatoms from a reagent that must be synthesized in advance. The new palladium strategy sidesteps much of this preparative burden by drawing both heteroatom sources directly from native, unprotected nucleophiles.

The choice of propargylic carbonates as the linchpin substrate reflects a decade of methodological development in palladium-catalyzed propargylic substitution. Because the η3-propargyl–palladium intermediate can react at different positions and through different mechanistic manifolds, controlling regio-, chemo- and enantioselectivity simultaneously has been a recognized challenge. Earlier work from the Chen group established regiodivergent syntheses of 1,3-dienyl and allyl esters from propargyl esters, and related studies across the field have harnessed these intermediates for allenylations, annulations and cascade dearomatizations. The present work adds a genuinely new dimension: using the intermediate’s dual electrophilicity not merely to diversify products, but to impose an ordering on competing nucleophiles.

Mechanistic evidence underpins the proposal. Time-course and kinetic studies traced the multicomponent alkenylation process and the roles of individual reaction components, while density functional theory calculations, carried out by Tingrui Liu with Bingnan Du, rationalized the orderly incorporation of the nucleophiles and mapped the energetic landscape of the competing pathways. Extended optimization studies probed how nucleophile basicity, expressed as pKa in water, influences the outcome, and control experiments without the bisphosphine ligand DPPB underscored its necessity. Crystallographic support came from X-ray structures deposited at the Cambridge Crystallographic Data Centre under deposition numbers CCDC 2212247 and 2418501, anchoring the stereochemical assignments that the enantiocontrol claims rest upon.

The broader conceptual payoff may prove as important as any individual product. The study demonstrates that subtle reactivity differences—differences far too small to exploit through conventional chemoselectivity—can be systematically harnessed when a catalyst offers multiple, mechanistically distinct reactive channels. In this sense the palladium complex functions less like a conventional reagent and more like a sorting machine, reading the nucleophilicity and coordinating affinity of each partner and dispatching it accordingly. The approach echoes recent advances in amine sorting for unsymmetrical diamines and ureas, and suggests a general design principle for programmable synthesis: rather than forcing all partners down a single reaction pathway, engineers of future multicomponent reactions may deliberately build catalysts with parallel, orthogonal channels tuned to the intrinsic properties of the molecules they wish to combine. For a field striving to make complex, enantiopure molecules directly from simple feedstocks with minimal waste, that is a compelling blueprint.

Subject of Research: Palladium-catalysed orthogonal multicomponent synthesis of enantiopure 1,2-amino alcohols

Article Title: Orthogonal nucleophile-ordered assembly for modular access to enantiopure 1,2-amino alcohols

Article References: Dai, M., Liu, T., Zhang, M., Zhang, L., Zhang, M., Song, L., Du, B., & Chen, L.-A. (2026). Orthogonal nucleophile-ordered assembly for modular access to enantiopure 1,2-amino alcohols. Nature Chemistry. https://doi.org/10.1038/s41557-026-02263-x

Image Credits: AI Generated

DOI: 10.1038/s41557-026-02263-x

Keywords: palladium catalysis, multicomponent reactions, 1,2-amino alcohols, asymmetric catalysis, propargylic carbonates, chemoselectivity, enantioselectivity, nucleophile sorting, propargyl-palladium complexes, synthetic methodology, chiral ligands, organic synthesis

The design is a layered piece of molecular engineering. At its core are multi-walled carbon nanotubes, the cylindrical rolls of graphitic carbon prized for their strength, conductivity, and enormous surface area. The researchers first deposited iron oxide (Fe₃O₄) nanoparticles onto the nanotube surfaces through in-situ co-precipitation, giving the material its magnetic personality. They then converted surface carboxylic acid groups into reactive acid chlorides using thionyl chloride, and coupled those with guanine—the same nitrogen-rich nucleobase found in DNA. Finally, copper(I) iodide was introduced, with the guanine’s nitrogen donor atoms gripping the Cu(I) centers in a stable coordination environment. The result, dubbed MWCNTs/MNPs-Gu-CuI, is a hybrid material combining a conductive carbon backbone, a magnetic core, a biomolecular linker, and catalytically active copper sites all in one nanostructure.

What makes the guanine layer more than decoration is its chemistry. Nitrogen-rich heterocycles like guanine are excellent ligands for transition metals, anchoring Cu(I) ions firmly enough to prevent leaching while keeping them accessible to substrates. According to the authors, this nucleobase framework stabilizes the copper centers and facilitates substrate activation, boosting both reaction rates and selectivity. It is an elegant example of borrowing a motif from biology—nature has been using nitrogen bases to coordinate metals for billions of years—and repurposing it for industrial-scale organic synthesis.

Characterization left little doubt that the assembly worked as designed. Fourier-transform infrared spectroscopy tracked each chemical transformation, from the appearance of Fe–O stretching bands around 580 to 620 wavenumbers after magnetite deposition to the emergence of N–H and amide carbonyl signals once guanine was grafted on, and finally to subtle shifts in nitrogen-containing vibrations upon copper coordination. X-ray diffraction confirmed the coexistence of the graphitic carbon peak near 26 degrees, the hallmark reflections of Fe₃O₄, and signals attributable to Cu(I) species and the organic ligand. Thermogravimetric analysis showed a total weight loss of roughly 29 percent up to 800 degrees Celsius, leaving about 71 percent inorganic residue—a sign of substantial, thermally stable content and a robust framework.

Microscopy and magnetometry filled in the physical picture. Scanning and transmission electron micrographs revealed nanotubes densely but uniformly decorated with small spherical nanoparticles, with no significant aggregation—a direct consequence of the guanine ligand stabilizing the particles and preventing clumping. Energy-dispersive X-ray spectroscopy confirmed the expected elemental inventory of carbon, nitrogen, oxygen, iron, copper, and iodine, while particle-size analysis showed an average diameter of approximately 71.84 nanometers. Inductively coupled plasma optical emission spectroscopy measured a copper loading of 1.29 × 10⁻³ moles per gram. Vibrating sample magnetometry demonstrated soft, near-superparamagnetic behavior with negligible coercivity, meaning the material responds strongly to a magnet yet demagnetizes instantly when the field is removed—ideal for rapid, clean separation.

With the catalyst in hand, the team optimized the reaction itself. The model transformation condenses a 2-bromobenzaldehyde, acetamide, and phenylacetylene in a one-pot, three-component annulation. Screening bases revealed that potassium acetate, a mild and non-nucleophilic choice, outperformed strong inorganic bases and organic amines alike; aggressive bases such as potassium tert-butoxide collapsed the yield to 15 percent, presumably through competing elimination and substrate degradation. Solvent screening proved equally decisive. Non-polar toluene managed only 29 percent yield, while the winning combination—PEG and water in a 2:1 ratio at 100 degrees Celsius—delivered 92 percent, later rising to 96 percent with the ideal 5 mole percent catalyst loading. Beyond that loading, yields plateaued, indicating the catalytic sites were saturated.

The substrate scope is where the method flexes its synthetic muscle. Across seventeen examples, yields ranged from 86 to 96 percent, encompassing electron-donating methyl and methoxy groups, electron-withdrawing chloro and bromo substituents, and demanding heteroaromatic rings including pyridyl, furyl, and thiophenyl units. That last category matters: coordinating heterocycles often poison copper catalysts, yet the guanine-anchored system kept working, a resilience the authors attribute to the strong immobilization of the metal centers. Even sterically hindered ortho-substituted substrates and multiply substituted dichloro compounds performed well, and the surviving halogen handles offer convenient hooks for later cross-coupling chemistry—a practical boon for medicinal chemists building molecular libraries.

Mechanistically, the reaction follows a copper-mediated sequence on the catalyst surface. The terminal alkyne first coordinates to Cu(I) through π-complexation, enhancing its nucleophilicity, while the aryl bromide undergoes oxidative addition to a neighboring copper center. Reductive elimination then forges the key carbon–carbon bond, after which nucleophilic attack by the amide component and intramolecular cyclization build the isoquinoline ring. A final aromatizing dehydrogenation releases the product and regenerates the catalyst, with water as the principal byproduct. A hot-filtration test provided the crucial control: removing the solid catalyst at the 90-minute mark froze conversion at roughly 48 percent, while the unfiltered reaction climbed to 96 percent. Catalysis, in other words, genuinely happens on the solid—no leached copper species are doing the work in solution.

The sustainability credentials are equally concrete. Compared with literature protocols, the new system outpaces a palladium method requiring 24 hours at 80 degrees Celsius, a ruthenium–copper system needing 12 hours in PEG-400, and a simple CuI/NaOH recipe that takes 48 hours in water. The PEG/water medium replaces volatile, toxic organic solvents with a low-toxicity, biodegradable mixture, and the magnetic separation eliminates filtration and centrifugation entirely. After seven consecutive runs, yields declined only from 96 to 86 percent, and post-use analysis showed the crystalline phases, functional groups, and magnetic response essentially intact—saturation magnetization fell only slightly, from 45.329 to 42.218 emu per gram, with copper content barely changed at 1.26 × 10⁻³ moles per gram.

The broader significance lies in the convergence of three ideas: nucleobase-functionalized nanomaterials as precision metal anchors, magnetic carbon nanohybrids as recoverable catalytic platforms, and green solvent systems as reaction media. By fusing them, the researchers have produced what they describe as the first guanine-anchored, MWCNT-supported Cu(I) magnetic nanocatalyst for multicomponent isoquinoline synthesis. If the approach generalizes to other heterocycles and metal-catalyzed transformations, it could shift how pharmaceutical intermediates are made—away from precious metals, harsh solvents, and wasteful workups, and toward catalysts that a magnet, a bottle of PEG, and a dash of water can keep in service for run after run.

Subject of Research: Development of a guanine-functionalized MWCNT-supported Cu(I) magnetic nanocatalyst for green, recyclable synthesis of isoquinoline derivatives in PEG/water

Article Title: Guanine-functionalized MWCNT-supported Cu(I) magnetic nanocatalyst for green synthesis of isoquinolines in PEG/H₂O

Article References: Daoud, E., Kareem, H. A.-D. H., Suleman, A. D., Raj, P. B., Ganesan, S., Surya, C. P., Chopra, L., & Mohammadi, R. (2026). Guanine-functionalized MWCNT-supported Cu(I) magnetic nanocatalyst for green synthesis of isoquinolines in PEG/H₂O. Journal of Saudi Chemical Society, 30(2), Article 22. https://doi.org/10.1007/s44442-026-00070-0

Image Credits: AI Generated

DOI: 10.1007/s44442-026-00070-0

Keywords: nanocatalysis, copper catalysis, isoquinoline synthesis, carbon nanotubes, magnetic nanoparticles, green chemistry, PEG/water solvent, guanine functionalization, multicomponent reactions, heterogeneous catalysis, catalyst recyclability, Fe3O4 nanoparticles

The Mannich reaction is deceptively simple. It condenses three components, typically an amine, formaldehyde or a related aldehyde, and a nucleophilic carbon center, into a single β-amino carbonyl product in one pot. Because the reaction tolerates an enormous range of substrates, it allows chemists to bolt aminomethyl groups onto almost any molecule bearing an acidic or nucleophilic carbon, instantly adding a basic, water-solubilizing handle that often improves binding to biological targets. Several FDA-approved heterocyclic drugs owe their existence to Mannich condensation, and the piperazine ring itself is prized for its conformational flexibility and its ability to engage in diverse interactions with proteins. Combining the two, the review’s authors contend, is a uniquely efficient way to generate the molecular diversity on which modern drug discovery depends.

The first major strategy surveyed is the classical three-component condensation. In one representative study, Janowska and colleagues reacted a substituted 1,2,4-triazole-3-thione with various piperazines and formaldehyde in ethanol at room temperature, obtaining antimicrobial Mannich bases in 32 to 62 percent yield within 24 hours, with products simply precipitating out of solution. Wujec and Typek used the same logic to prepare a single triazole-thione derivative in 81 percent yield in anhydrous ethanol. Perhaps most compelling for clinicians, several teams have grafted piperazine Mannich motifs onto existing fluoroquinolone antibiotics. Coupling ciprofloxacin or norfloxacin with piperazine derivatives and formaldehyde in dimethylformamide at room temperature delivered hybrid antibacterial compounds in yields of 71 to 83 percent, demonstrating that the reaction can upgrade established drugs rather than merely decorate novel cores.

The breadth of pharmacological classes reachable through this chemistry is remarkable. Avci and co-workers attached piperazine-containing Mannich arms to a naproxen scaffold, producing analgesic and anti-inflammatory candidates in 20 to 82 percent yield in boiling ethanol. Fan and colleagues condensed methylxanthines with piperazines under reflux to obtain fungicidal derivatives in 82 to 95 percent yield, among the highest reported in the review. Oxadiazole-thiones reacted with formaldehyde and substituted piperazines overnight at room temperature furnished anti-inflammatory and antimicrobial products spanning 29 to 89 percent yield, while coumarin and eupatilin derivatives made by the same logic showed anti-proliferative and antitumor activity against multiple human cancer cell lines. Even eugenol, the clove-derived phenol, was converted into a DPPH-scavenging antioxidant hybrid in 83 percent yield using N-methyl piperazine and excess formaldehyde in methanol.

The second strategy category involves multicomponent variations in which the Mannich step is performed last, after more complex frameworks have already been assembled. This late-stage aminomethylation is powerful because it lets chemists build elaborate molecular architecture first and then install the piperazine-containing pharmacophore with surgical precision. Rawat and colleagues, for example, first converted a triazole-5-thione with anisaldehyde into a Schiff base, then reacted that intermediate with piperazine and formaldehyde to reach the final antifungal product in 65 percent yield. Loganathan’s group pushed the concept further with a five-component sequence, condensing benzotriazole, para-nitrobenzaldehyde and piperazine into an intermediate that was subsequently coupled with amines and aldehyde to give antibacterial heterocycles in 83 to 87 percent yield against E. coli and Streptococcus.

Isatin, the indole-derived ketone that has become a favorite scaffold in anticancer research, features prominently in this section. Teams led by Raju, Verma and Mohamed all followed the same general blueprint: form an isatin Schiff base with an aromatic amine under acetic acid catalysis, then perform the Mannich condensation with formaldehyde and a piperazine derivative. The resulting hybrids, obtained in yields from 45 to 87 percent, showed anticancer and antibacterial activity, and the authors of the review walk through the detailed mechanistic proposal, in which protonated isatin undergoes nucleophilic attack, dehydration, and imine formation before the piperazine nitrogen delivers the final aminomethyl group. Nitrofuran-isatin hybrids made by a catalyst-free variant reached 80 to 85 percent yield with simple overnight stirring in ethanol.

The third and most forward-looking section catalogues catalytic and green approaches that address the classical reaction’s environmental shortcomings. Copper salts emerge as the stars of this show. Copper chloride enabled a one-pot synthesis of a maleopimaric acid derivative with striking antiviral activity against influenza A (H1N1), achieving an IC50 of 0.9 micromolar in just four hours at room temperature. Copper iodide promoted the coupling of N-propargylated triterpenic indoles with piperazines and formaldehyde at 60 degrees Celsius, yielding compounds active against SARS-CoV-2, and also drove the synthesis of oxadiazole kinase inhibitors and benzodioxole-piperazine hybrids at room temperature in dimethyl sulfoxide. Indium chloride catalyzed fluoroquinolone-triazole hybrids in yields up to 95 percent, while simple acetic acid and hydrochloric acid proved sufficient for indole-piperazine and benzimidazole systems.

Microwave assistance delivers perhaps the most dramatic efficiency gains. Albelwi and co-workers showed that triazole-based Mannich bases could be made in ethanol with significantly higher yields and drastically shorter reaction times under microwave irradiation compared with conventional heating, a result that matters for scale-up because microwave protocols cut both energy consumption and solvent load. The review also highlights catalyst-free protocols run in water-tolerant conditions, solvent-free setups, and recyclable catalytic systems, all of which align the chemistry with the principles of sustainable synthesis. The authors note that these greener methods do not merely reduce waste; they frequently improve regioselectivity, a persistent problem when asymmetric piperazines can react at either nitrogen to give isomeric mixtures that are difficult to purify.

The biological payoff of all this synthetic ingenuity is documented in detail. An oxadiazole-piperazine Mannich base bearing a benzyl substituent showed IC50 values as low as 6.49 micromolar against breast cancer cells, while a triazole-based MMP inhibitor reached 0.390 micromolar against colon adenocarcinoma and was flagged as drug-like by ADMET prediction. Structure-activity relationships repeatedly showed that bulky, basic piperazine substituents enhance potency, and that electron-withdrawing groups on aromatic rings boost antifungal activity. Against tuberculosis, an indole-based N-benzylated Mannich base achieved an MIC of 1.6 micrograms per milliliter against Mycobacterium tuberculosis H37Rv. The review closes with a look ahead: the authors anticipate solvent-free methodologies, C-H activation to widen substrate scope, biocatalytic variants, and integration with photoredox and flow chemistry platforms. If those predictions hold, the Mannich reaction, now more than a century old, may spend its next hundred years at the center of drug discovery’s most productive chemistry.

Subject of Research: Mannich-type multicomponent synthesis of functionalized piperazine-based bioactive scaffolds

Article Title: Multicomponent mannich-type approaches to the synthesis of functionalized piperazine-based bioactive scaffolds

Article References: Mubashra, S., Ahmad, M., Aslam, S., Al-Hussain, S. A., & A. Zaki, M. E. (2026). Multicomponent mannich-type approaches to the synthesis of functionalized piperazine-based bioactive scaffolds. Journal of Saudi Chemical Society, 30(3), Article 43. https://doi.org/10.1007/s44442-026-00095-5

Image Credits: AI Generated

DOI: 10.1007/s44442-026-00095-5

Keywords: piperazine, Mannich reaction, multicomponent reactions, medicinal chemistry, green chemistry, anticancer agents, antiviral agents, antibacterial agents, heterocyclic compounds, copper catalysis, microwave-assisted synthesis, drug discovery

Polyhydroquinolines are not laboratory curiosities. These nitrogen-containing ring systems, close cousins of the dihydropyridine scaffolds found in calcium-channel blockers, have been linked to an impressive range of pharmacological activities, including hepatoprotective, antidiabetic, geroprotective, bronchodilator, vasodilator, antiatherosclerotic and antitumor effects. Related structures have also shown antiplasmodial, antibacterial and antimalarial activity. Because of this versatility, medicinal chemists have spent decades searching for efficient ways to assemble them, and the classic route traces all the way back to 1882, when Arthur Hantzsch first described a one-pot condensation of an aldehyde, a beta-ketoester and ammonia in acetic acid or ethanol.

The Hantzsch reaction is a prime example of a multicomponent reaction, a strategy in which three or more starting materials combine in a single step to form a product that incorporates most of the atoms of the reactants. Multicomponent reactions are prized for their atom economy and for slashing the number of synthetic steps required to reach complex heterocyclic scaffolds. Yet many modern versions of the polyhydroquinoline synthesis still carry baggage: metal salts that complicate separation, ionic liquids that are costly, catalysts that cannot be reused, or solvents that generate waste. The new study set out to strip away as much of that baggage as possible.

The researchers’ catalyst of choice, PFPAT, is a non-metallic organoammonium salt whose design is deceptively simple but chemically clever. The strongly electron-withdrawing pentafluorophenyl group, paired with a weakly coordinating triflate anion, makes the ammonium proton unusually acidic. That acidity allows PFPAT to activate carbonyl compounds through proton transfer and hydrogen-bonding interactions, the key first move in the multicomponent condensation. Because the catalyst is a metal-free organic salt, it avoids many of the separation and recyclability problems that plague soluble metal catalysts, particularly when reactions are scaled up.

The model reaction combined benzaldehyde, ethyl acetoacetate, dimedone and ammonium acetate, with reaction progress tracked by thin-layer chromatography. Without any catalyst, the mixture yielded only trace product even after prolonged reaction, and heating to 90 degrees Celsius alone brought only marginal improvement, a clear sign that thermal activation is not enough. When PFPAT was introduced, the picture changed dramatically. Raising the catalyst loading from 2.5 to 10 mole percent steadily improved both yield and reaction time, and 10 mole percent at 90 degrees Celsius emerged as the optimum. Pushing the loading further, to 12.5 or 15 mole percent, offered no meaningful benefit, indicating that the active catalytic sites were already sufficient for efficient conversion.

Solvent screening reinforced the green credentials of the protocol. The team tested acetonitrile, chloroform, dimethyl sulfoxide and dichloromethane, and even the best performer, DMSO, managed only a moderate 68 percent yield with longer reaction times. Nothing matched the solvent-free system. Under the optimized conditions, the model product was isolated in 86 percent yield in just three hours, with the crude solid obtained by simple filtration, washed with a minimal volume of ethyl acetate and petroleum ether, and purified by recrystallization from hot aqueous ethanol. The work-up is deliberately mundane, which is precisely the point for a procedure intended to be practical.

To benchmark PFPAT against the competition, the researchers ran the same model reaction with a lineup of commercially available Lewis and Brønsted acid catalysts under identical conditions. Metal salts such as zinc chloride, iron(III) chloride and iron(III) iodide delivered conversions of only 60 to 72 percent with isolated yields of 38 to 50 percent. The lanthanide triflate La(OTf)3 fared better at 85 percent conversion and 65 percent yield, while p-toluenesulfonic acid and heterogeneous titanium dioxide pushed past 90 percent conversion with yields above 70 percent over five hours. PFPAT outperformed them all, achieving complete conversion and an 86 percent yield in three hours. Calculated turnover numbers told the same story: PFPAT posted the highest TON of 8.6 and TOF of 2.87 per hour among the catalysts tested, reflecting its strong Brønsted acidity and its knack for accelerating the cyclocondensation under mild, solvent-free conditions.

The substrate scope revealed a clear and chemically satisfying pattern. Eleven substituted benzaldehydes were converted into their polyhydroquinoline products, spanning electron-donating groups such as methyl, methoxy and hydroxy as well as electron-withdrawing halogens and nitro groups. Electron-poor aldehydes reacted fastest and best: 4-nitrobenzaldehyde gave its product in 94 percent yield within just 1.5 hours, while electron-rich 4-methoxybenzaldehyde needed four hours and delivered 78 percent. The explanation lies in the first step of the mechanism, a Knoevenagel condensation in which the aldehyde carbonyl must be attacked. Electron-withdrawing substituents make the carbonyl carbon more electrophilic, speeding both the condensation and the subsequent cyclization, whereas electron-donating groups dampen electrophilicity and slow the cascade. The consistent trend across substrates suggests the catalytic system has a general affinity for electron-deficient aromatic aldehydes, a useful guide for anyone planning to apply the method.

Mechanistically, the reaction unfolds as a classic Hantzsch-type sequence. PFPAT first activates the aldehyde carbonyl through hydrogen bonding and acid interactions, priming it for nucleophilic attack. Ammonium acetate then reacts with ethyl acetoacetate to generate an enamine intermediate, while dimedone undergoes a PFPAT-catalyzed Knoevenagel condensation with the activated aldehyde to form a reactive alpha,beta-unsaturated intermediate. The enamine adds to this activated olefin in a Michael-type addition, followed by intramolecular cyclization and tautomerization to close the polyhydroquinoline ring. The catalyst’s ability to promote proton transfers and stabilize charged intermediates through each of these stages is what allows the whole cascade to proceed smoothly without solvent.

Recyclability, often the Achilles heel of homogeneous catalysts, proved to be a genuine strength here. After each run, PFPAT was recovered simply by extraction with ethyl acetate, dried under vacuum and reused without any further treatment. The catalyst retained its activity effectively through four consecutive cycles, with only a slight loss attributable to partial solubility in the aqueous phase. On the fifth cycle, performance dropped more sharply, with product yield falling to 70 percent and catalyst recovery to 63 percent, but the overall pattern still marks PFPAT as a viable, eco-friendly option for repeated use. Combined with yields of 72 to 94 percent across the substrate range, short reaction times, operational simplicity and the complete elimination of reaction solvents, the protocol offers a template for sustainable heterocyclic synthesis. The authors suggest that future work could expand the substrate scope, probe the biological activities of the products, and evaluate whether the process can be scaled for industrial application, a prospect that would bring a 140-year-old reaction firmly into the era of green chemistry.

Subject of Research: Green solvent-free Brønsted acid-catalyzed synthesis of polyhydroquinoline derivatives via Hantzsch multicomponent reaction

Article Title: An optimized and sustainable Brønsted acid-catalyzed green synthesis of polyhydroquinoline derivatives

Article References: Pande, P., Niralwad, K., & Patki, A. (2026). An optimized and sustainable Brønsted acid-catalyzed green synthesis of polyhydroquinoline derivatives. Discover Chemistry, 3(1), Article 551. https://doi.org/10.1007/s44371-026-00996-9

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00996-9

Keywords: polyhydroquinolines, PFPAT, green chemistry, Hantzsch reaction, Brønsted acid catalysis, multicomponent reactions, solvent-free synthesis, catalyst recyclability, heterocyclic chemistry, drug discovery, Knoevenagel condensation, sustainable synthesis

The original call for papers read like a catalogue of the field’s hottest frontiers: targeted protein degradation, molecular glues, covalent inhibitors, antibody-drug conjugates, macrocycles, nucleoside therapeutics, immuno-oncology agents, natural-product discovery, multicomponent reactions, advanced imaging and screening technologies, and artificial intelligence. That breadth is significant in itself. A decade ago, many of these approaches were considered speculative or confined to a handful of specialist laboratories. Today they constitute a mainstream toolkit, and the 58 accepted articles show researchers across medicinal chemistry, chemical biology, and pharmacology routinely combining them rather than working in silos. The result, according to the editorial framing the collection, is a discovery enterprise that is faster, more efficient, and increasingly sophisticated in how it approaches molecular design.

A central theme running through the issue is the development of efficient and diversity-oriented synthetic strategies for bioactive molecules. The published articles describe asymmetric and visible-light-promoted reactions, multicomponent and one-pot syntheses, iron-catalyzed functionalization, nanocatalytic and sonochemical methods, skeletal editing, total synthesis, and optimized synthetic routes. Each of these techniques addresses a persistent bottleneck in drug discovery: the speed and reliability with which chemists can actually make the molecules that computational and biological studies suggest might work. Visible-light photocatalysis, for example, allows bond formations under mild conditions that were previously difficult or impossible, while skeletal editing permits late-stage modifications of molecular frameworks that would once have required rebuilding a candidate from scratch. Multicomponent reactions compress multi-step sequences into single operations, dramatically shortening the path from idea to testable compound.

Crucially, the synthetic advances described in the collection are not presented as ends in themselves. The resulting compounds, which include diverse indoles, indolizines, heterocycles, molecular hybrids, peptides, and natural-product analogues with enhanced structural and stereochemical complexity, were investigated as anticancer, antimicrobial, antitubercular, antiviral, anti-inflammatory, antidiabetic, antiseizure, and neuroprotective agents. This direct linkage between methodology and biological application is what distinguishes the current wave of synthetic innovation from earlier eras in which method development and drug hunting often proceeded on separate tracks. When a new catalytic reaction can be evaluated within weeks against disease-relevant cell models, the feedback loop between chemistry and pharmacology tightens, and the odds that an interesting molecule becomes a therapeutic candidate improve accordingly.

Another striking pattern in the collection is the continuing shift beyond the traditional one drug-one target paradigm that dominated pharmaceutical research for much of the past half-century. Among the highlighted examples are dual inhibitors targeting BTK/FLT3, COX-2/5-LOX, and FAAH/sEH, enzyme pairs relevant to cancer and inflammation, alongside multifunctional agents designed for Alzheimer’s disease and reviews of xanthone hybrids and pyrazolopyrimidine-based dual inhibitors. Multi-target design acknowledges that complex diseases rarely hinge on a single protein, and that modulating several nodes of a pathological network simultaneously can be more effective than maximal blockade of one. The approach demands a different kind of medicinal chemistry, one in which selectivity is engineered across multiple binding sites rather than maximized against a single target, and the articles in the issue show that scaffold design and mechanistic understanding are being integrated to meet exactly that challenge.

The issue also surveys work on established and emerging molecular targets, including FAK, HDAC, ERα, PI3Kδ, p38 MAPK, EZH2, DprE1, histamine H1 and H2 receptors, SFRP1, PDE4B, and nitric oxide synthase. This list spans kinases, epigenetic enzymes, nuclear receptors, phosphodiesterases, and bacterial cell-wall biosynthesis machinery, reflecting the wide biological terrain on which modern medicinal chemistry now operates. A dedicated review on PROTAC technology underscores the prominence of targeted protein degradation, one of the most promising new therapeutic modalities of the past decade. Rather than inhibiting a protein’s activity, degraders recruit cellular disposal machinery to eliminate the disease-causing protein altogether, an approach that can succeed against targets long considered undruggable by conventional small molecules. Its inclusion alongside classical target families illustrates how new modalities are being folded into, rather than replacing, the existing discovery apparatus.

Natural products and biomolecule-inspired scaffolds remain a major focus of the collection, and the evidence assembled suggests that nature is far from exhausted as a source of molecular diversity. Studies on phorbazole D, menominin A, polyprenylated acylphloroglucinols, oleanolic and alepterolic acids, Eucommiae folium, µ-conotoxins, honey-bee antimicrobial peptides, and marine cyclopeptides demonstrate the remarkable chemical inventiveness of the natural world, from terrestrial plants to venomous cone snails and social insects. What has changed is the technology brought to bear on these molecules. Total synthesis, analogue generation, chemical ligation, mass spectrometry, network pharmacology, and cell-based screening are overcoming longstanding challenges in natural-product discovery and optimization, problems of supply, structural complexity, and limited optimization potential that historically kept many natural products out of the clinic despite compelling biological activity.

The synergy between computation and experimentation emerges as perhaps the defining feature of the modern discovery pipeline. Molecular docking, molecular dynamics simulations, pharmacophore modeling, network pharmacology, and integrated in silico-in vitro workflows now support compound prioritization and mechanistic studies across the collection. These are not decorative additions; they determine which of millions of conceivable molecules get synthesized and tested, effectively allocating scarce laboratory resources. AI-assisted analysis, label-free cell-based screening, high-resolution LC-Orbitrap mass spectrometry, and zebrafish disease models further illustrate advances in compound characterization, phenotypic screening, and translational validation. Phenotypic screening in whole organisms such as zebrafish is particularly notable, because it allows compounds to be evaluated for efficacy and toxicity in a living system before the costly transition to mammalian models, catching failures earlier and more cheaply than traditional pipelines allow.

The collective message of the 58 articles is that new technologies in drug discovery are not defined by any single platform or methodology, but by the integration of innovative chemistry, emerging therapeutic modalities, computational prediction, advanced screening technologies, and rigorous biological validation. This multidisciplinary convergence is expanding druggable chemical space, the universe of molecules that can realistically be made, characterized, and developed into medicines, while accelerating therapeutic discovery and enabling increasingly sophisticated approaches to drug design. For decades, the pharmaceutical industry has grappled with declining productivity per research dollar, and collections like this one suggest a credible path forward: rather than betting on any single breakthrough, the field is stacking multiple incremental advantages in synthesis, target biology, computation, and screening into compounding gains across the entire pipeline.

In closing the special issue, Shi thanks the authors, reviewers, and the editorial team of Molecular Diversity, and expresses the hope that the collection will stimulate new collaborations, inspire continued technological innovation, and contribute to making drug discovery faster, more efficient, and more successful while preserving the molecular and mechanistic diversity that underpins transformative medicines. That emphasis on diversity is more than rhetorical. History shows that transformative drugs often emerge from unexpected chemical territory, and the deliberate cultivation of varied scaffolds, modalities, and screening strategies is the best insurance against the field narrowing prematurely around fashionable targets. If the technologies surveyed here continue to mature and interconnect, the coming decade of drug discovery may look markedly different from the last, with molecules designed, synthesized, and validated at a pace and precision that earlier generations of researchers could scarcely have imagined.

Subject of Research: Emerging technologies and multidisciplinary approaches in drug discovery

Article Title: New technologies in drug discovery

Article References: Shi, T. (2026). New technologies in drug discovery. Molecular Diversity. https://doi.org/10.1007/s11030-026-11711-2

Image Credits: AI Generated

DOI: 10.1007/s11030-026-11711-2

Keywords: drug discovery, medicinal chemistry, targeted protein degradation, PROTAC, molecular glues, natural products, artificial intelligence, multicomponent reactions, phenotypic screening, dual inhibitors, chemical biology, Molecular Diversity

Enaminones are among the most versatile building blocks in synthetic and medicinal chemistry. Their conjugated enamine-carbonyl system hosts multiple reactive sites, allowing them to serve as linchpins in multicomponent reactions that rapidly assemble heterocycles and polyfunctionalized alkenes. They also appear in numerous drug-discovery programs as pharmacophores and intermediates. Adding a methylthio group to the enaminone framework further expands their utility, because organosulfur motifs are pervasive in bioactive molecules and can tune lipophilicity, binding geometry, and redox behavior.

The twist in this work is the deuterium. Replacing the three hydrogens of a methyl group with deuterium can dramatically alter how a molecule behaves in a biological system. Because carbon-deuterium bonds are stronger than carbon-hydrogen bonds, metabolic enzymes that would normally strip a methyl group through hydrogen abstraction are slowed or stopped, a phenomenon known as the kinetic isotope effect. This principle underlies deuterated drugs such as deutetrabenazine and donanemab-adjacent programs, and it has fueled intense interest in methods that install trideuteromethyl groups late in a synthesis. Installing a trideuteromethylthio group, a sulfur atom carrying a CD3 substituent, is even more challenging, since conventional methylthiolation reactions rely on isotopically light reagents or harsh oxidative conditions.

Classic approaches to methylthiolation have leaned on dimethyl sulfoxide, dimethyl disulfide, or sodium thiomethoxide in combination with palladium, copper, cobalt, or silver catalysts, or on strong bases such as potassium tert-butoxide. These protocols can work well for aryl and heteroaryl systems, but they typically deliver unlabeled methylthio groups, demand transition metals, or generate substantial waste. Electrochemistry offers an alternative: by applying electrons directly at an electrode, chemists can generate reactive radical intermediates under ambient conditions without stoichiometric chemical oxidants, and the only byproduct at the counter electrode is often hydrogen gas.

In the new protocol, the researchers found that ammonium iodide acts as a redox mediator. At the anode, iodide is oxidized to iodine or related iodine radicals, which in turn activate the Bunte salt, sodium CD3SSO3Na, to release the trideuteromethylthio radical. Meanwhile, acetylacetone condenses with the primary amine in situ to form the enaminone nucleophile. The sulfur radical couples to the electron-rich enaminone, and the second electrode completes the redox cycle, closing the cascade. Because all three components converge in one pot, the method avoids prefunctionalized enaminones, metal catalysts, and external oxidants.

The scope of the reaction proved impressively broad. Aromatic amines bearing electron-donating and electron-withdrawing substituents, halogens, and sensitive functional groups all furnished the corresponding trideuteromethylthiolated enaminones in good yields, and aliphatic amines were also tolerated. The team demonstrated gram-scale synthesis, a critical test for any method aspiring to medicinal chemistry adoption, and applied the chemistry to late-stage modification of bioactive molecules, showing that the electrosynthetic conditions are gentle enough to leave complex pharmacophores untouched.

The biological payoff emerged from preliminary screening of the compound library. One derivative, designated compound 4l, protected cells from oxidative damage by activating the Nrf2/HO-1 signaling pathway, a master regulator of the cellular antioxidant response. Under oxidative stress, Nrf2 translocates to the nucleus and upregulates heme oxygenase-1 and other cytoprotective genes. A small molecule that nudges this pathway could hold promise for conditions ranging from neurodegeneration to inflammatory disease, although the authors stress that the screening was preliminary and that structure-activity relationships remain to be mapped.

Why the deuterium matters for such activity is not yet fully resolved, but the isotope could influence the compound’s metabolic stability, redox properties, or binding interactions, and the labeled products also serve as ideal internal standards for mass spectrometry-based pharmacokinetic studies. Deuterium labeling is increasingly used in ADME research, in mechanism-of-action investigations, and in patent strategies that extend the lifespan of known drugs. A method that can access trideuteromethylthiolated scaffolds in one operation, using electricity and inexpensive sodium salts, gives medicinal chemists a tool that was previously unavailable.

The work also fits into a broader movement toward organic electrosynthesis. Over the past decade, electrochemistry has migrated from the periphery of synthetic chemistry to its center, powering C-H functionalizations, cross-couplings, and radical cascades that once required expensive catalysts or hazardous oxidants. The Wenzhou group has previously used CD3SSO3Na in electrochemical aminotrideuteromethylthiolation of isocyanides and dual C-H functionalization of indoles; the present study extends that reagent family to enaminones, one of the most productive scaffold classes in multicomponent chemistry.

Looking ahead, the combination of green electrosynthesis, isotopic labeling, and early biological validation points toward a workflow in which potentially therapeutic molecules are not only made sustainably but also interrogated for function from the first library onward. If compounds like 4l survive further optimization, the humble Bunte salt and a pair of electrodes may have opened an unexpectedly direct road from the electrolysis cell to the antioxidant medicine cabinet.

Subject of Research: Electrochemical three-component cascade synthesis of antioxidant trideuteromethylthiolated enaminones using Bunte salts

Article Title: Electrochemical synthesis of antioxidant trideuteromethylthiolated enaminones through three-component cascade reactions

Article References: Wang, J., Wang, L., Zhang, W., Liu, Y., Ni, D., Wu, G., & Wu, Y. (2026). Electrochemical synthesis of antioxidant trideuteromethylthiolated enaminones through three-component cascade reactions. Molecular Diversity. https://doi.org/10.1007/s11030-026-11732-x

Image Credits: AI Generated

DOI: 10.1007/s11030-026-11732-x

Keywords: electrochemistry, deuterium labeling, trideuteromethylthiolation, enaminones, Bunte salts, multicomponent reactions, organic synthesis, antioxidant, Nrf2/HO-1 pathway, medicinal chemistry, green chemistry, radical cascade